2015 Florida Best Practice Psychotherapeutic Medication Guidelines for Adults: A Focus on Mixed Features presented by Roger McIntyre, MD, FRCPC on March 29, 2017.
The DSM-5 introduced new sets of criteria for major depressive disorder and bipolar disorder. An important and significant change was the elimination of mixed states, which were supplanted with the mixed features specifier. The mixed features specifier could apply to adults either with major depressive disorder or bipolar disorder. This recent change has historical, conceptual, clinical, and therapeutic implications. Healthcare providers often encounter individuals experiencing mixed features, which have demonstrated to be less responsive to conventional antidepressant therapy. The Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder or Bipolar Disorder are the most up-to-date treatment guidelines providing decision support for healthcare providers involved in the care of affected individuals. This presentation briefly reviewed the rationale for changes to mixed features, as well as introduced and operationalize the mixed features specifier. The treatment approach, informed by the aforementioned guidelines, was presented and reviewed.
For more information on our Program, electronic copies of our best practice psychotherapeutic medication guidelines, and other resources visit our website [ Ссылка ].
